Lipid-lowering Efficacy and Safety of Policosanol on Cardiovascular Diseases in the Very Old Patients

摘要：

OBJECTIVE: The aim of the study was to comparatively observe policosanol”s lipid-lowering efficacy and safety in the very old patients with cardiovascular diseases.METHODS: 294 elderly patients with dyslipidemia were included.All patients were randomly divided into four groups: Policosanol 20mg group (group A, n =64);Policosanol 10mg group (group B, n =72);atorvastatin 20mg group (group C, n =91);policosanol 10mg + atorvastatin 20mg group (group D, n =62).The following indexes were observed at 0d, 12th week, 24th week and 52th week: TC, TG, LDL-C, HDL-C, Lp (a), ApoA1, ApoB, ALT, AST, CK, and Mb.

作者: Y.Ding Q.J.Si

作者单位: Department of Geriatric Cardiology, Chinese PLA General Hospital, Beijing,China Healthcare Department 2, Hainan Branch of Chinese PLA General Hospital, Sanya, China

会议类型: 国内会议

会议名称: 2015中国老年医学和老年健康产业大会

会议地点: 苏州

会议语种:英文

页码: 150-151

在线出版日期: 2015-09-11（万方平台首次上网日期，不代表论文的发表时间）